Marker Therapeutics GAAP EPS of -$1.59, revenue of $3.31M
Marker Therapeutics GAAP EPS of -$1.59, revenue of $3.31M
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Perspective Therapeutics GAAP EPS of -$0.14, revenue of $1.43M
SeekingAlpha
-
Gyre Therapeutics GAAP EPS of -$1.41, revenue of $113.5M
SeekingAlpha
-
eFFECTOR Therapeutics GAAP EPS of -$3.42, revenue of $0M
SeekingAlpha
-
Stoke Therapeutics GAAP EPS of -$0.60 beats by $0.02, revenue of $2.8M misses by $0.42M
SeekingAlpha
Advertisement
More coverage
-
Tango Therapeutics GAAP EPS of -$0.32 misses by $0.04, revenue of $5.43M misses by $2.81M
SeekingAlpha
-
HLS Therapeutics GAAP EPS of -$0.17 misses by $0.04, revenue of $15.86M misses by $5.84M
SeekingAlpha
-
Century Therapeutics GAAP EPS of -$2.30, revenue of $2.2M
SeekingAlpha
-
Entrada Therapeutics GAAP EPS of -$0.29 beats by $0.81, revenue of $41.85M
SeekingAlpha